Monday, June 8, 2026
spot_img

Don't Miss

Partnerships and M&A

Micro Imaging Technology acquires Cellmyx

0
Micro Imaging technology, a California-based public company symbol (MMTC), announced the acquisition of Cellmyx, a great addition to MIT's portfolio of companies in the...

Bluecore brings its aesthetic laser portfolio to the U.S. via partnership with Powered by MRP

Evolus debuts HA gel collection

Solta Medical’s Thermage receives China trademark recognition

Pluri advances toward U.S. commercial launch through its subsidiary Cellav

Clinical Trials

Clinical Trials

Allergan Aesthetics receives positive CHMP opinion for Boey across Europe

0
Allergan Aesthetics, an AbbVie company and global leader in medical aesthetics, announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human...
Clinical Trials

Lumenis Aesthetics showcases new clinical data across skin and hair loss indications

0
Lumenis Be Ltd., a leading energy-based medical device company for aesthetic and eye care applications, announced new clinical data from its portfolio of industry-leading...

Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 ‘302’ Clinical Trial

Cutia Therapeutics’ Botox Rival meets Phase III goals in China

Obagi Medical shares new clinical data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum

VISTA Trial validates noninvasive tool for skin feature identification

EVENTS

Funding

Funding

Conexeu Sciences commences trading on Nasdaq under ticker symbol “CNXU”

0
Conexeu Sciences Inc., a biotechnology company advancing tissue regeneration, announced it has officially commenced trading on the Nasdaq today under the ticker symbol “CNXU.”...

W-Wellness secures strategic funding

Plcoskin secures $2 Million from Highlight Capital

Galderma welcomes increased equity investment from L’Oréal

Charterhouse Capital Partners announces investment in Winback

- Advertisement -

Featured

Latest Reviews

Partnerships and M&A

Micro Imaging Technology acquires Cellmyx

0
Micro Imaging technology, a California-based public company symbol (MMTC), announced the acquisition of Cellmyx, a great addition to MIT's portfolio of companies in the...

Bluecore brings its aesthetic laser portfolio to the U.S. via partnership with Powered by MRP

Evolus debuts HA gel collection

Mergers & Acquisitions

Micro Imaging Technology acquires Cellmyx

0
Micro Imaging technology, a California-based public company symbol (MMTC), announced the acquisition of Cellmyx, a great addition to MIT's portfolio of companies in the...

Bluecore brings its aesthetic laser portfolio to the U.S. via partnership with Powered by MRP

0
In an effort to expand safe and effective treatment options for patients historically underserved by aesthetic lasers, Powered by MRP today announced an exclusive...

Waldencast announces sale of Obagi Medical to Bridgepoint

0
Waldencast plc announced that it has entered into a definitive agreement to sell its Obagi Medical dermatological skincare and aesthetics business to Bridgepoint, one...

$200M merger of Dominion and BellaMia creates new laser robotic leader

0
Dominion Aesthetic Technologies, Inc. and BellaMia Technologies, Inc. announced they have completed a strategic merger. Dominion is the creator of EON®, the leader in...

Koru Pharma announces strategic partnership with LYFE Capital

0
Koru Pharma is pleased to announce a strategic partnership with LYFE Capital, a global healthcare investment firm. As part of this agreement, LYFE Capital...
- Advertisement -
Advertismentspot_imgspot_img
Advertismentspot_imgspot_img

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Driving Growth in Aesthetics Globally

Over the past decade, we have successfully sourced talent for 40+ Medical Aesthetics companies across 20+ countries, completing over 350+ searches. Leveraging our extensive network and deep industry expertise, we have supported businesses at various growth stages, driving innovation in the sector.

Contact us: contact@ValuraNova.com